127 related articles for article (PubMed ID: 8981054)
1. The dermorphin peptide family.
Melchiorri P; Negri L
Gen Pharmacol; 1996 Oct; 27(7):1099-107. PubMed ID: 8981054
[TBL] [Abstract][Full Text] [Related]
2. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
Negri L; Lattanzi R; Melchiorri P
Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
[TBL] [Abstract][Full Text] [Related]
3. Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine.
Mizoguchi H; Bagetta G; Sakurada T; Sakurada S
Peptides; 2011 Feb; 32(2):421-7. PubMed ID: 21126548
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
5. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.
Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM
Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345
[TBL] [Abstract][Full Text] [Related]
6. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
7. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin.
Broccardo M; Erspamer V; Falconieri Erspamer G; Improta G; Linari G; Melchiorri P; Montecucchi PC
Br J Pharmacol; 1981 Jul; 73(3):625-31. PubMed ID: 7195758
[TBL] [Abstract][Full Text] [Related]
9. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.
Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of amphibian opiate peptides.
Negri L; Melchiorri P; Lattanzi R
Peptides; 2000 Nov; 21(11):1639-47. PubMed ID: 11090917
[TBL] [Abstract][Full Text] [Related]
11. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
[TBL] [Abstract][Full Text] [Related]
12. Spinal action of dermorphin, an extremely potent opioid peptide from frog skin.
Stevens CW; Yaksh TL
Brain Res; 1986 Oct; 385(2):300-4. PubMed ID: 2877713
[TBL] [Abstract][Full Text] [Related]
13. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.
Negri L; Lattanzi R; Tabacco F; Scolaro B; Rocchi R
Br J Pharmacol; 1998 Aug; 124(7):1516-22. PubMed ID: 9723966
[TBL] [Abstract][Full Text] [Related]
14. Endomorphin-1 analogs with oligoarginine-conjugation at C-terminus produce potent antinociception with reduced opioid tolerance in paw withdrawal test.
Yuan BY; Liu WZ; Wang XF; Zhang YZ; Yang DJ; Wang CL
Peptides; 2018 Aug; 106():96-101. PubMed ID: 30016700
[TBL] [Abstract][Full Text] [Related]
15. Comparison of opioid activity between a N-terminal tetrapeptide analogue of dermorphin, H-Tyr-D-Arg-Phe-beta-Ala-OH and morphine.
Sato T; Takahashi N; Tan-No K; Kisara K; Sakurada T; Sakurada S
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):581-6. PubMed ID: 9819802
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide.
Hochrainer N; Serafin P; D'Ingiullo S; Mollica A; Granica S; Brytan M; Kleczkowska P; Spetea M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612817
[TBL] [Abstract][Full Text] [Related]
18. Opioid ligands with extraordinarily high mu-selectivity: dermorphin tetrapeptides containing thymine-modified alanine residues.
Kharkevich DA; Sumbatyan NV; Topin AN; Chichenkov ON; Zaitsev SV; Korshunova GA
FEBS Lett; 1994 Sep; 351(3):308-10. PubMed ID: 7915993
[TBL] [Abstract][Full Text] [Related]
19. Lack of involvement of mu(1) opioid receptors in dermorphin-induced inhibition of hypoxic and hypercapnic ventilation in rat pups.
Colman AS; Miller JH
Respir Physiol Neurobiol; 2002 Aug; 131(3):199-212. PubMed ID: 12126921
[TBL] [Abstract][Full Text] [Related]
20. Dermorphin analogues containing D-kyotorphin: structure-antinociceptive relationships in mice.
Kisara K; Sakurada S; Sakurada T; Sasaki Y; Sato T; Suzuki K; Watanabe H
Br J Pharmacol; 1986 Jan; 87(1):183-9. PubMed ID: 2869809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
